Later in the day, a pair of lots sold for $200,000 respectively to secure their placings as the joint-second-top lots on the second day of trade.
Lot 273, the first of the duo to go under the hammer, is a filly by Yulong’s Written Tycoon who sold to Ridgeport Holdings, Clarken Bloodstock, and Suman Hedge Bloodstock (FBAA).
The filly is out of Blue Morpho (Hussonet) who from 16 starts on the track managed three wins, including landing the 2018 Laelia Stakes (Listed, 1600m).
Clarken and his training partner Niki O’Shea know about the family, with the filly’s brother, the unraced Windrow, and her Alabama Express half-sister, who Clarken bought for $80,000 at the Inglis Premier Yearling Sale in 2021, both residents of their Murray Bridge stable.
“The quality always makes money and there have been some really nice types and there’s been no doubt that they have been well received. We were narrowly beaten on the Zoustar filly [Lot 255] earlier today and we were lucky enough to get the Written Tycoon filly a second ago,” Will Clarken told ANZ Bloodstock News.
“I’ve got her two relations who have shown great promise and haven’t been to the races yet. Written Tycoon has been a good stallion to the yard and we’ve got Kuroyanagi who was Group 1-placed in the Blue Diamond and it’s going to be for the same ownership group [Ridgeport].”
“We’ve got four so far [on the day], we’ve been sent a few and I think there’s a couple more on the list for the rest of the day, but we really came here to buy what we thought was the best filly and the best colt and I think we’ve done that.
“Adelaide has been a really happy hunting ground for us. We bought Beau Rossa here and he was narrowly beaten in a Group 1. I bought Galaxy Patch out of here, Prawn Baba and both of them have run in a Hong Kong Derby [Galaxy Patch second in 2024] and I just know the sale and it’s been really good for us.
“Let’s hope the Magic Millions lives on here in South Australia. Obviously there are some changes ahead, but it’s a great asset to have a sale in our backyard.”
Story from ANZ Bloodstock News